Open access
Sep 2026
Efficacy and Safety of Reduced-Dose Chemotherapy Plus Nivolumab in Elderly Advanced Gastric Cancer
Reduced-dose chemotherapy plus nivolumab may be an effective and less toxic first-line option for elderly patients with AGC, according to retrospectively collected clinical data from 70 patients aged 70 years or older with AGC.
Toshihiko Matsumoto, S. Sugimoto, R. Omori et al.
· Gastroenterology Insights · 0 citations